U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07280234) titled 'Comparison of Intradermal Microinjections of Tanexamic Acid and Oral Tranexamic Acid in the Management of Melasma.' on Nov. 28.
Brief Summary: In this study we compared the effect of intradermal microinjections of tranexamic acid vs oral tranexamic acid in treatment of melasma. Given the high prevalence of melasma in Pakistan and the significant psychosocial impact on patients, particularly in Peshawar, this study will provide valuable insights into optimal treatment strategies
Study Start Date: Nov. 14, 2024
Study Type: INTERVENTIONAL
Condition:
Melasma
Intervention:
DRUG: Intradermal microinjections of tranexamic acid
This ...